Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

BACKGROUND: Several clinical studies have established the efficacy, safety, and tolerability of long-acting risperidone administered once every 2 weeks in patients with schizophrenia or schizoaffective disorder. This report evaluates preliminary efficacy, safety, tolerability, and pharmacokinetic da...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gharabawi, Georges M, Gearhart, Natalie C, Lasser, Robert A, Mahmoud, Ramy A, Zhu, Young, Mannaert, Erik, Naessens, Ineke, Bossie, Cynthia A, Kujawa, Mary, Simpson, George M
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2007
Matèries:
Primary Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1803785/
https://ncbi.nlm.nih.gov/pubmed/17261186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1744-859X-6-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars